As simultaneous analysis of various markers could potentially increase prognostic significance over individual markers, we have used a multi-marker approach, using TMAs, to investigate the relevance of several EGFR pathway-related markers and their association with NSCLC patient prognosis. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.